FK866, a nicotinamide phosphoribosyltransferase inhibitor, which binds to Toll-like receptor 4 (TLR4) and activates the inflammasome [253], was evaluated to determine its efficacy against brain reperfusion damage in rats subjected to cardiac arrest/cardiopulmonary resuscitation. The gene discussed is TLR4; the disease is cardiac arrest.